Old Web
English
Sign In
Acemap
>
authorDetail
>
C. Propert-Lewis
C. Propert-Lewis
The Royal Marsden NHS Foundation Trust
Medicine
Pathology
Leiomyosarcoma
Toxicity
Sarcoma
6
Papers
39
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase II study of gemcitabine and docetaxel as first-line chemotherapy in locally advanced/metastatic leiomyosarcoma
2016
Journal of Clinical Oncology
Beatrice Seddon
Michelle Scurr
Robin L. Jones
Z. Wood
C. Propert-Lewis
Roger A'Hern
Jeremy Whelan
Ian Judson
Show All
Source
Cite
Save
Citations (3)
A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcoma
2015
Clinical sarcoma research
Beatrice Seddon
Michelle Scurr
Robin L. Jones
Zoe Wood
C. Propert-Lewis
Cyril Fisher
Adrienne M. Flanagan
Jonanthan Sunkersing
Roger A’Hern
Jeremy Whelan
Ian Judson
Show All
Source
Cite
Save
Citations (34)
Creatinine clearance and serum albumin as factors for encephalopathy with ambulatory 14-day infusional ifosfamide for advanced liposarcomas.
2011
Journal of Clinical Oncology
Salma Alam
Charlotte Benson
Robin L. Jones
Eirini Thanopoulou
Scott Mitchell
Omar Al-Muderis
Alison Dunlop
C. Propert-Lewis
Ian Judson
Michelle Scurr
Show All
Source
Cite
Save
Citations (0)
Chemotherapy in advanced pleomorphic sarcomas: The experience of the Royal Marsden Hospital (RMH).
2011
Journal of Clinical Oncology
Eirini Thanopoulou
Charlotte Benson
Omar Al-Muderis
Cyril Fisher
C. Propert-Lewis
Alison Dunlop
Ian Judson
Michelle Scurr
Show All
Source
Cite
Save
Citations (0)
1